🇺🇸 FDA

Intelligence Platform

Patents

Browse 28 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 12053477

Methods for treating pulmonary fibrosis

REVIVA PHARMACEUTICALS, INC. · Granted Tue Aug 06 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 01 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10441590

Methods for treating pulmonary hypertension

REVIVA PHARMACEUTICALS, INC. · Granted Tue Oct 15 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 10 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10035761

Compositions, synthesis, and methods of using phenylcycloalkylmethylamine derivatives

REVIVA PHARMACEUTICALS, INC. · Granted Tue Jul 31 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 26 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9975862

Arylpiperazine derivatives and methods of utilizing same

REVIVA PHARMACEUTICALS, INC. · Granted Tue May 22 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 17 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9907803

Methods for treating attention deficit hyperactivity disorder

REVIVA PHARMACEUTICALS, INC. · Granted Tue Mar 06 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9695116

Compositions, synthesis, and methods of using phenylcycloalkylmethylamine derivatives

REVIVA PHARMACEUTICALS, INC. · Granted Tue Jul 04 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 29 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9604944

Arylpiperazine derivatives and methods of utilizing same

REVIVA PHARMACEUTICALS, INC. · Granted Tue Mar 28 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9302981

Synthesis, methods of using, and compositions of cycloalkylmethylamines

REVIVA PHARMACEUTICALS, INC. · Granted Tue Apr 05 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 31 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9296681

Cycloalkylmethylamines

REVIVA PHARMACEUTICALS, INC. · Granted Tue Mar 29 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 24 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9255076

Arylpiperazine derivatives and methods of utilizing same

REVIVA PHARMACEUTICALS, INC. · Granted Tue Feb 09 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 04 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9238625

Compositions, synthesis, and methods of using phenylcycloalkylmethylamine derivatives

REVIVA PHARMACEUTICALS, INC. · Granted Tue Jan 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9096515

Methods of using cycloalkylmethylamine derivatives

REVIVA PHARMACEUTICALS, INC. · Granted Tue Aug 04 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 30 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8980883

Arylpiperazine derivatives and methods of utilizing same

REVIVA PHARMACEUTICALS, INC. · Granted Tue Mar 17 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8859552

Methods of utilizing arylpiperazine derivatives

REVIVA PHARMACEUTICALS, INC. · Granted Tue Oct 14 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 09 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8669285

Synthesis, methods of using, and compositions of cycloalkylmethylamines

REVIVA PHARMACEUTICALS, INC. · Granted Tue Mar 11 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8604244

Compositions, synthesis, and methods of using cycloalkylmethylamine derivatives

REVIVA PHARMACEUTICALS, INC. · Granted Tue Dec 10 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 05 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8580822

Compositions, synthesis, and methods of using indanone based cholinesterase inhibitors

REVIVA PHARMACEUTICALS, INC. · Granted Tue Nov 12 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 07 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8575185

Compositions, synthesis, and methods of utilizing quinazolinedione derivatives

REVIVA PHARMACEUTICALS, INC. · Granted Tue Nov 05 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 31 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8461154

Methods of utilizing arylpiperazine derivatives

REVIVA PHARMACEUTICALS, INC. · Granted Tue Jun 11 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 06 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8445714

Cycloalkylmethylamines

REVIVA PHARMACEUTICALS, INC. · Granted Tue May 21 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 16 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8431570

Methods of utilizing arylpiperazine derivatives

REVIVA PHARMACEUTICALS, INC. · Granted Tue Apr 30 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 25 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8372883

Methods of using cycloalkylmethylamines

REVIVA PHARMACEUTICALS, INC. · Granted Tue Feb 12 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 07 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8338632

Cycloalkylmethylamines

REVIVA PHARMACEUTICALS, INC. · Granted Tue Dec 25 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8247420

Compositions, synthesis, and methods of using quinolinone based atypical antipsychotic age

REVIVA PHARMACEUTICALS, INC. · Granted Tue Aug 21 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 16 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted